Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -31.79M | -20.33M | |
| Total Depreciation and Amortization | -- | -- | 1.87M | 1.90M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | 21.65M | 11.19M | |
| Change in Net Operating Assets | -- | -- | 4.07M | -58.00K | |
| Cash from Operations | -- | -- | -4.19M | -7.30M | |
| Capital Expenditure | -- | -- | -405.00K | -498.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | 0.00 | |
| Other Investing Activities | -- | -- | -22.56M | -20.63M | |
| Cash from Investing | -- | -- | -22.97M | -21.12M | |
| Total Debt Issued | -- | -- | 30.18M | 28.18M | |
| Total Debt Repaid | -- | -- | -2.50M | -2.39M | |
| Issuance of Common Stock | -- | -- | 7.66M | 7.12M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -6.52M | -7.66M | |
| Cash from Financing | -- | -- | 28.81M | 25.24M | |
| Foreign Exchange rate Adjustments | -- | -- | -174.00K | -240.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | 1.48M | -3.42M | |